Jennifer Cautela
Inserm · 116 works · 7,282 citations · h-index 30
Top works
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
- Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related Cardiotoxicity
- Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
- Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
- Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis
- Etiology of Pericarditis in a Prospective Cohort of 1162 Cases
- Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis
- Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: a pilot study
- Management of Low Blood Pressure in Ambulatory Heart Failure with Reduced Ejection Fraction Patients
- Takotsubo-Like Syndrome in Cancer Patients Treated With Immune Checkpoint Inhibitors
- Infective Endocarditis: Prevention, Diagnosis, and Management
- Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors
- Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis
- Immune checkpoint inhibitor-associated myocarditis: a novel risk score
- High incidence of atrial fibrillation in patients treated with ibrutinib
- Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry
- Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor–induced Myocarditis
- Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
- Prevalence and characteristics of coronary artery disease in heart failure with preserved and mid-range ejection fractions: A systematic angiography approach